AstraZeneca’s Imfinzi and Imjudo found to extend survival in liver cancer trial

AstraZeneca’s Imfinzi and Imjudo found to extend survival in liver cancer trial

Submitted by admin on September 17, 2024 - 10:52am
Source: 
Clinical Trials Arena
News Tags: 
AstraZeneca
Imfinzi
Imjudo
liver cancer
clinical trials
Headline: 
AstraZeneca’s Imfinzi and Imjudo found to extend survival in liver cancer trial
snippet: 

AstraZeneca has reported positive results from the Phase III HIMALAYA trial of Imfinzi plus Imjudo in advanced liver cancer patients.

Do Not Allow Advertisers to Use My Personal information